Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 27Active not recruiting 9Terminated 2Unknown 1Suspended 1Recruiting 1

Sponsor Class

OTHER 8NETWORK 2OTHER_GOV 1NIH 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1

Conditions

Breast Neoplasms 104Lymphoma 78Lung Neoplasms 68Colorectal Neoplasms 61Carcinoma, Non-Small-Cell Lung 60Rectal Neoplasms 58Leukemia 56Colonic Neoplasms 56Lymphoma, Follicular 42Precursor Cell Lymphoblastic Leukemia-Lymphoma 39Central Nervous System Neoplasms 39Lymphoma, Large B-Cell, Diffuse 38Prostatic Neoplasms 35Ovarian Neoplasms 33Melanoma 33Lymphoma, Non-Hodgkin 33Head and Neck Neoplasms 32Burkitt Lymphoma 31Leukemia, Lymphocytic, Chronic, B-Cell 30Carcinoma, Ovarian Epithelial 30Lymphoma, Large-Cell, Immunoblastic 28Kidney Neoplasms 28Multiple Myeloma 26Lymphoma, Mantle-Cell 26Lymphoma, B-Cell, Marginal Zone 25Carcinoma, Renal Cell 25Sarcoma 24Neoplasms, Plasma Cell 24Leukemia, Myeloid, Acute 24Hodgkin Disease 23

Interventions

Temozolomide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × NIH × Rhabdomyosarcoma × Clear all
NCT00003718 2014-01-06

Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma

National Cancer Institute (NCI)

Phase 2 Unknown
25 enrolled
GynecologicSarcoma

Malignant mesenchymal tumor, Hemangiopericytoma, Malignant, Chondrosarcoma, Extraskeletal Myxoid, Fibrosarcoma, Hemangiosarcoma, Leiomyosarcoma, Liposarcoma, Ovarian Neoplasms, Rhabdomyosarcoma, Sarcoma, Sarcoma, Synovial, Endometrial Neoplasms, Sarcoma, Endometrial Stromal, Sarcoma, Alveolar Soft Part, Neurofibrosarcoma, Histiocytoma, Malignant Fibrous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡